OTLY · Oatly Group AB · Stock research

Current Thesis

The leg being bought is an operating-inflection story on a heavily levered balance sheet. On 2026-07-22 Oatly reported Q2 net revenue of $240.1M, +15.2% reported and +12.7% in constant currency, against a $218.961M consensus (Benzinga), and lifted FY2026 constant-currency revenue growth guidance to 8–10% from 3–5%. Adjusted EBITDA came in at +$0.4M versus -$3.6M a year earlier and gross margin was 33.9%, up 140bps. Barclays kept Overweight and moved its target to $14 on 2026-07-23, two days after cutting it to $12 on 2026-07-21.

What that does not fix is the capital structure: $44.6M of cash against $517.8M of total borrowings at 2026-06-30, with management pointing to the low end of the $25–35M FY adjusted-EBITDA range. The equity is a call option on the growth guide holding. As of the 2026-08-07 close of $13.72, RSI(14) sits at 71.0, the three-month return is +31.8%, and the shares are still 26.0% under the $18.54 52-week high.

Life-cycle: ACCELERATING. Dated to the 2026-07-22 print and the 2026-07-23 Barclays revision — new numbers, a guide that doubled, fresh momentum-screen coverage. It is not MATURING because the re-rating has not reclaimed the prior 52-week range, and not SATURATED because sell-side participation is thin (JPMorgan and Morgan Stanley both at hold in late July 2026).

Bullish and bearish views on Oatly Group AB

The model's bull view on Oatly Group AB (OTLY), in brief: FY2026 constant-currency revenue growth guidance raised to 8–10% from 3–5% on 2026-07-22 — a doubling of the growth assumption inside one quarter. The bear view: Leverage dominates the equity. $517.8M total borrowings vs $44.6M cash at 2026-06-30. The 9.25% Convertible Senior PIK Notes due 2028-09-14 accrete interest rather than pay it in cash, so principal compounds absent repurchase. The September 2025 refinancing (SEK 1,700M Nordic… Both cases follow in full.

Bull Case

• FY2026 constant-currency revenue growth guidance raised to 8–10% from 3–5% on 2026-07-22 — a doubling of the growth assumption inside one quarter.
• Q2 2026 revenue $240.095M vs $218.961M consensus; EPS -$0.99 vs -$1.06 consensus (Benzinga, 2026-07-22). Six-month revenue $468.4M.
• Adjusted EBITDA crossed positive at +$0.4M (vs -$3.6M in Q2 2025) with gross margin at 33.9%, +140bps. Net loss narrowed to $31.3M from $55.9M.
• Regional breadth: Europe & International +21.0% reported / +18.0% constant currency; Greater China +11.6% / +5.6% cc; North America +5.9% with a second consecutive quarter of positive volume growth (Q2 2026 release).
• Capital intensity is low relative to the growth rate: H1 2026 capex $10.7M.
• Barclays Overweight, PT $14 (2026-07-23); MarketBeat-tracked average target $14.64 — both marks sit above the 2026-08-07 close of $13.72.

Bear Case

• Leverage dominates the equity. $517.8M total borrowings vs $44.6M cash at 2026-06-30. The 9.25% Convertible Senior PIK Notes due 2028-09-14 accrete interest rather than pay it in cash, so principal compounds absent repurchase. The September 2025 refinancing (SEK 1,700M Nordic bonds, SEK 750M super senior RCF, prepayment of the $130M Term Loan B) reshuffled the stack without taking leverage to a level that $25–35M of adjusted EBITDA covers comfortably.
• The dollar guide raise — from $866.725M–$883.555M to $908.799M–$925.629M — landed against a $917.899M consensus (Benzinga, 2026-07-22). The midpoint closed the gap to the Street rather than clearing it.
• FX flattered the quarter. Reported growth 15.2% vs 12.7% constant currency is roughly 250bps of currency help. Oatly reports in USD while its largest growth region is European.
• Management guided adjusted EBITDA toward the low end of $25–35M on the 2026-07-22 call, citing cost pressure and growth spend.
• Still a loss-maker: -$31.3M net in the quarter. JPMorgan and Morgan Stanley both at hold ratings, late July 2026.
• Shares remain -26.0% from the $18.54 52-week high (2026-08-07 basis), so the guidance raise has recovered part of a prior de-rating rather than establishing new highs.

Setup & Price Structure

• Last completed daily close $13.72 (2026-08-07). 52-week high $18.54. Three-month return +31.8%. RSI(14) 71.0 — the overbought band.
• The move is anchored to a single dated event. The advance to $13.72 is therefore concentrated in the weeks following 2026-07-22, consistent with a 71 RSI reading.
• Spot sits under the $14.64 average target and under Barclays' $14, so the published marks leave little headroom absent estimate revisions.

Crowding and positioning observables (stated, not judged):

• On 2026-07-24, two days after the print, Benzinga listed OTLY in "Top 3 Defensive Stocks That May Collapse This Quarter" — an RSI-based overbought screen. Momentum-screen coverage clustered within 48 hours of the catalyst.
• No scheduled company earnings event inside the next 30 days to reprice the guide.
• Barclays cut its target to $12 on 2026-07-21 and raised it to $14 on 2026-07-23 — a two-day round trip set to the print.
• Extension without recovery: price is 26% below the 52-week high while RSI reads 71, so the overbought condition has arrived inside a downtrend repair rather than at new highs.

Catalyst Calendar (next 30 days)

• 2026-08-08 to 2026-09-07: no confirmed company-scheduled event. Nothing on the public IR calendar as of 2026-08-08. The window is empty and the guidance raise has to carry the tape unaided.
• ~2026-10-28 (est.) — Q3 2026 results. Basis for the estimate: Q3 2025 was reported 2025-10-29 and Q3 2024 on 2024-11-07. Not confirmed by the company as of 2026-08-08. This is the first hard test of the 8–10% constant-currency guide and of whether adjusted EBITDA tracks the low or high end of $25–35M.
• Interim disclosure: Form 6-K filings are ad hoc for a foreign private issuer — there is no quarterly 10-Q cadence to anchor to.

What Would Change Our Mind

The load-bearing number is the FY constant-currency growth guide. If the Q3 print walks 8–10% back toward the old 3–5% band, or narrows adjusted EBITDA below the $25M low end already flagged on the 2026-07-22 call, the reason the multiple moved on 2026-07-22 is gone and the leverage is what remains.

Second, the currency. Q2 reported growth ran roughly 250bps above constant currency. If Q3 reported growth prints below constant-currency growth, the $908.799M–$925.629M dollar guide is at risk with no operational deterioration required.

Third, the capital structure. An equity issuance, ATM programme or dilutive refinancing announced into this strength would say management treats $13.72 as a funding level rather than a re-rating.

On price, a weekly close below $11.00 would cede the full advance that followed the 2026-07-22 guidance raise and put the shares back inside the pre-print range. A shift of the theme to SATURATED — broad retail coverage without incremental estimate revisions — is the softer secondary condition.

What would extend the leg instead: adjusted EBITDA tracking toward $35M rather than $25M, North America volume growth holding for a third consecutive quarter, or a refinancing that removes the 9.25% PIK coupon.

Correlation Notes

• FX is a direct P&L input. EUR/USD and SEK/USD drive the reported-versus-constant-currency spread; Europe & International grew +21.0% reported against +18.0% cc in Q2 2026.
• Credit matters more than staples beta. With $517.8M of borrowings against $44.6M cash, the shares behave closer to a leveraged-credit proxy than to a packaged-food comp. SEK-denominated Nordic bond spreads and the 2028 convertible are the relevant read-across.
• Greater China exposure ties a segment to tariff and geopolitical headlines; the Q2 2026 call flagged geopolitical dynamics alongside the +5.6% cc growth there.
• Plant-based / alt-dairy complex: category scanner data and competitor retail pricing move the cohort together, though Oatly is repositioning as a broader beverage business rather than a dairy-alternative pure play.
• Small-cap consumer momentum cohort: with RSI at 71 and the advance concentrated into a few weeks, the shares carry exposure to momentum-factor unwinds independent of company news.